基于网络药理学和动物实验的八桂天龙散调控MAPK/NF-κB信号通路防治肝性脑病作用机制研究OA
Investigating the mechanism of Bagui Tianlong Powder(八桂天龙散)in regulating the MAPK/NF-κB signaling pathway against hepatic encephalopathy via network pharmacology and animal experiments
目的 采用网络药理学和动物实验探讨八桂天龙散防治肝硬化并发肝性脑病(HE)的作用机制.方法 通过数据库筛选八桂天龙散的活性成分、药物靶点以及HE的疾病靶点,预测八桂天龙散防治HE的药效靶点和作用机制.采用CCl4联合TAA构建肝硬化并发HE大鼠模型,随机分为模型组、八桂天龙散低、中、高剂量组(0.27、0.54、1.08 g·kg-1)和布洛芬组(0.05 g·kg-1),并设置正常对照组,于造模第5周开始进行预防给药,连续4周,通过观察大鼠一般状态,Morris水迷宫实验检测学习记忆能力,苏木精-伊红染色观察肝组织和海马组织病理变化,Nissl染色观察海马神经元形态,测定血氨和肝功能指标,ELISA法检测海马组织肿瘤坏死因子(TNF)-α、白细胞介素(IL)-10、IL-6水平,实时荧光定量聚合酶链式反应(RT-qPCR)和蛋白免疫印迹法(Western blot)检测MAPK/NF-κB信号通路表达情况.结果 网络药理学分析提示八桂天龙散可能参与调控MAPK信号通路、NF-κB信号通路等多条信号通路发挥拮抗HE的作用.动物实验结果表明,八桂天龙散可改善HE模型大鼠的精神状态,增加自主性活动,缓解认知功能障碍,减轻肝组织和海马组织的病理损伤,减少海马神经元形态不规则、排列紊乱、空泡化等现象,改善血氨和肝功能,降低促炎因子TNF-α、IL-6水平以及升高抗炎因子IL-10水平,下调p38 MAPK、NF-κB p65、IκBα的mRNA表达,降低p-p38 MAPK/p38 MAPK、p-NF-κB p65/NF-κB p65、p-IκBα/IκBα的蛋白表达比值.结论 八桂天龙散对肝硬化并发HE大鼠具有防治效应,其作用机制可能通过调控MAPK/NF-κB信号通路减轻神经炎症,保护神经元,从而改善认知功能障碍.
Objective To explore the mechanism of Bagui Tianlong Powder(八桂天龙散,BGTLP)in preventing and treating hepatic encephalopathy(HE)complicating liver cirrhosis using network pharmacology and animal experiments.Methods Network pharmacol-ogy was employed to screen the active ingredients and potential targets of BGTLP against HE.A rat model of HE with cirrhosis was induced by carbon tetrachloride(CCl ₄)and thioacetamide(TAA).Rats were randomly assigned to the following groups:model,BGTLP-(0.27 g·kg⁻¹),medium-(0.54 g·kg⁻¹),high-dose(1.08 g·kg⁻¹),ibuprofen(0.05 g·kg⁻¹),and normal control.Preventive treatment started at week 5 post-modeling and continued for 4 weeks.Assessments included:general state;learning and memory(Morris water maze);histopathology of liver and hippocampal tissues(hematoxylin-eosin/HE and Nissl staining);blood ammonia and liver function indices;hippocampal levels of tumor necrosis factor-α(TNF-α),interleukin-10(IL-10),and IL-6(ELISA);and expression of the MAPK/NF-κB signaling pathway(real-time quantitative PCR and Western blot(WB)).Results Network analysis sug-gested BGTLP might act against HE by modulating pathways including MAPK and NF-κB signaling.Animal experiments demonstrated that BGTLP improved mental state and spontaneous activity,alleviated cognitive dysfunction,reduced pathological damage in liver and hippocampal tissues,attenuated hippocampal neuronal abnormalities(irregularity,disarray,vacuolation),improved blood ammonia and liver function,decreased pro-inflammatory(TNF-α,IL-6)and increased anti-inflammatory(IL-10)cytokine levels,down-regulated mRNA expression of p38 MAPK,NF-κB p65,and IκBα,and reduced the protein expression ratios of p-p38 MAPK/p38 MAPK,p-NF-κB p65/NF-κB p65,and p-IκBα/IκBα.Conclusion BGTLP exerts preventive and therapeutic effects in rats with cirrho-sis and HE.Its mechanism likely involves alleviating neuroinflammation and protecting neurons via regulation of the MAPK/NF-κB sig-naling pathway,thereby improving cognitive dysfunction.
陈玮钰;王涵;王明刚;冯雯倩;杜洋;颜璐怡;姚凡;付蕾;姚春
广西中医药大学研究生院,广西 南宁 530001广西中医药大学第一附属医院,广西 南宁 530000广西中医药大学第一附属医院,广西 南宁 530000广西中医药大学研究生院,广西 南宁 530001广西中医药大学研究生院,广西 南宁 530001广西中医药大学研究生院,广西 南宁 530001广西中医药大学第一附属医院,广西 南宁 530000广西中医药大学中药壮瑶药创新药物教育部工程研究中心、区域重大病种创新产品研发广西高校工程研究中心,广西 南宁 530001广西中医药大学第一附属医院,广西 南宁 530000||广西中医药大学中药壮瑶药创新药物教育部工程研究中心、区域重大病种创新产品研发广西高校工程研究中心,广西 南宁 530001
医药卫生
八桂天龙散肝性脑病网络药理学MAPK/NF-κB信号通路认知功能障碍
Bagui Tianlong Powder(八桂天龙散)Hepatic encephalopathyNetwork pharmacologyMAPK/NF-κB signaling pathwayCognitive dysfunction
《时珍国医国药》 2026 (16)
3156-3167,12
广西中药壮瑶药多学科交叉创新团队(GZKJ2301)广西研究生教育创新计划项目(YCBZ2024149)广西疑难重症中医诊疗研究团队项目(2022A001)姚春桂派中医大师传承工作室项目(GZY2024002)国家中医药管理局高水平中医药重点学科建设项目-中医内科学(zyyzdxk-2023166)国家自然科学基金地区基金(82260899)广西重点研发计划项目(桂科AB22035076)
评论